RecruitingNCT06100991
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Sponsor
CorEvitas
Enrollment
200 participants
Start Date
Sep 19, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with generalized pustular psoriasis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06100991